2010 Annual Meeting | Poster Session 04

Date Wednesday 04/14/10

Time 03:00 PM - 07:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Anterior Horn, Autonomic Disorders, Behavioral Neurology, Headache, Infections/AIDS/Prion Disease, MS and Related Diseases, Neuroepidemiology/Health Services and Outcomes Research, Neurogenetics and Gene Therapy, Neurologic ��ɫ��, Neurotoxicology, Peripheral Nerve

CME Available No CME available

Event Timeline
03:00 PM - 04:30 PM		Break
03:00 PM - 07:30 PM	Abstract	001 - Reversible Hypohidrosis with Topiramate Therapy for Chronic Migraine
03:00 PM - 07:30 PM	Abstract	002 - Headache and Neurological Deficits with Cerebrospinal Fluid Lymphocytosis (HaNDL): Could It Be an Autoimmune Disease?
03:00 PM - 07:30 PM	Abstract	003 - Application of the Kano Methodology for Evaluating Migraine Treatment Expectations among Neurologists in Spain. The MIGREXX Study
03:00 PM - 07:30 PM	Abstract	004 - High Migraine Frequency May Be Associated with Increased Interictal Platelet Activation in Episodic Migraine
03:00 PM - 07:30 PM	Abstract	005 - Response of SUNCT (Short-Lasting Unilateral Neuralgiform Headaches with Conjunctival Injection and Tearing), SUNA (Short-Lasting Unilateral Neuralgiform Headaches with Autonomic Symptoms) and Primary Stabbing Headaches to Occipital Nerve Stimulation (ONS)
03:00 PM - 07:30 PM	Abstract	006 - Lifetime Anxiety Symptoms in Migrainous Vertigo
03:00 PM - 07:30 PM	Abstract	007 - Evaluation of Efficacy and Safety of MAP0004 in Reversing Central Sensitization and Treating Migraine in Established Allodynic Patients
03:00 PM - 07:30 PM	Abstract	008 - The Timing of Gastric Stasis in an Acute Migraine and Its Impact on Treatment
03:00 PM - 07:30 PM	Abstract	009 - Occipital Neuralgia as an Isolated Symptom of Bone Metastasis Caused by Hepatocellular Carcinoma
03:00 PM - 07:30 PM	Abstract	010 - Posttraumatic and Postsurgical Nummular Headache
03:00 PM - 07:30 PM	Abstract	011 - Clinical Phenotypes and Morphological Changes of the Circle of Willis in Migraineurs
03:00 PM - 07:30 PM	Abstract	012 - Syncopal Migraine: Migraine as a Cause of Syncope
03:00 PM - 07:30 PM	Abstract	013 - Putative Clinical, Mechanical and Local Paracrine Mechanisms of Pituitary Adenoma-Attributed Headache
03:00 PM - 07:30 PM	Abstract	014 - Spinal Subdural Collection in the Setting of a Spontaneous Cerebrospinal Fluid Leak
03:00 PM - 07:30 PM	Abstract	015 - The Headache Under-Response to Treatment (HURT) Index: An Instrument Developed by the Lifting the Burden Campaign To Improve Management of Headache, Especially in Primary Care
03:00 PM - 07:30 PM	Abstract	016 - Scleral Buckle as a Unique Cause of Facial Pain
03:00 PM - 07:30 PM	Abstract	017 - Determinants of Migraine-Related Disability
03:00 PM - 07:30 PM	Abstract	018 - Magnetic Resonance Perfusion Imaging in Hemiplegic Migraine
03:00 PM - 07:30 PM	Abstract	019 - Migrainous Vertigo Presenting in the Perimenopause
03:00 PM - 07:30 PM	Abstract	020 - Spatial Vision, Intellectual Loss and Neuroimaging Variables as Predictors of Constructional Apraxia in Patients with Cerebrovascular Disease
03:00 PM - 07:30 PM	Abstract	021 - Spatially Adherent Graphemic Perseveration
03:00 PM - 07:30 PM	Abstract	022 - Atypical Presentation of Cerebellar Mutism in an Adult
03:00 PM - 07:30 PM	Abstract	023 - Effect of ��ɫ�� on Severity of Language Dysfunction after Stroke
03:00 PM - 07:30 PM	Abstract	024 - Narrative Discourse in Parkinson Disease
03:00 PM - 07:30 PM	Abstract	025 - You Don't Say: A New Variant of PPA?
03:00 PM - 07:30 PM	Abstract	026 - Quantifier Comprehension in Corticobasal Syndrome and Frontotemporal Degeneration
03:00 PM - 07:30 PM	Abstract	027 - Extrapyramidal Signs in Primary Progressive Aphasia
03:00 PM - 07:30 PM	Abstract	028 - Impaired Decision-Making Strategies for Pronoun Resolution in Behavioral-Variant Frontotemporal Dementia (bvFTD)
03:00 PM - 07:30 PM	Abstract	029 - Language Circuits Investigated with Semantic Decision/Tone Decision fMRI Task and Independent Component Analysis (ICA)
03:00 PM - 07:30 PM	Abstract	030 - Double Dissociation of Semantic and Episodic Memory Impairment in Temporal Variant Frontotemporal Dementia and Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	031 - False Recognition of Unfamiliar Faces in Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	032 - Loss of Future Oriented Behavior in a Patient with Behavioral Variant Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	033 - MRI Features Mimicking Limbic Encephalitis and CJD in Hashimoto's Encephalopathy without Paraneoplastic Antibodies
03:00 PM - 07:30 PM	Abstract	034 - Profiles of Performance in Verbal Serial List Learning in Alzheimer's Disease and Semantic Dementia
03:00 PM - 07:30 PM	Abstract	035 - Patterns of Memory Deficit Modify the Rate of Conversion to Dementia in a Large Sample of Patients with Mild Cognitive Impairment
03:00 PM - 07:30 PM	Abstract	036 - Graphabulation, a New Form of Confabulation
03:00 PM - 07:30 PM	Abstract	037 - Vitamin D, Fall Frequency, and Cognitive Function in Free-Living Elders
03:00 PM - 07:30 PM	Abstract	038 - Prospective Evaluation of 32 Patients with Symptoms of Transient Global Amnesia (TGA) in a Community Hospital of Argentina
03:00 PM - 07:30 PM	Abstract	039 - Hyposmia, Central Cholinergic Integrity and Cognitive Impairment in Parkinson Disease without Dementia
03:00 PM - 07:30 PM	Abstract	040 - Dissociation between Two Routes to Action in Gesture Imitation
03:00 PM - 07:30 PM	Abstract	041 - Gait Disorders, an Interesting Marker of Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	042 - Validation of a Simple Bedside Antisaccade Task in Neurodegenerative Dementia
03:00 PM - 07:30 PM	Abstract	043 - Reckless Driving Associated with Dopamine Agonist Use: A Case Series
03:00 PM - 07:30 PM	Abstract	044 - Right Inferior Frontal Gyrus Is Necessary for Interference Suppression, but Not Error Correction, in the Eriksen Flanker Task
03:00 PM - 07:30 PM	Abstract	045 - Executive Functions and Cognition in Amyotrophic Lateral Sclerosis
03:00 PM - 07:30 PM	Abstract	046 - Insight of Involuntary Movements in Early Huntington's Disease: A Simple Explanation
03:00 PM - 07:30 PM	Abstract	047 - Relationship between Cognition and Spatiotemporal Gait Parameters in Parkinson Disease without Dementia
03:00 PM - 07:30 PM	Abstract	048 - Quantification of Increased Mirror Overflow in ADHD: Laterality and Gender Effects
03:00 PM - 07:30 PM	Abstract	049 - Excessive Hoarding in Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	050 - Neuropsychological Profile of Adult Patients with Duchenne Muscular Dystrophy
03:00 PM - 07:30 PM	Abstract	051 - Trends in Outcomes and Hospitalization Costs among Patients with Warding's Hoffman Disease in the United States
03:00 PM - 07:30 PM	Abstract	052 - The Role of Ulnar Compound Muscle Action Potential (U-CMAP) as a Surrogate Outcome Measure in Ambulatory Adults with Spinal Muscular Atrophy (AA-SMA)
03:00 PM - 07:30 PM	Abstract	053 - Beta-Lactam Antibiotics Offer Neuroprotection in a Spinal Muscular Atrophy Mouse Model by Multiple Mechanisms
03:00 PM - 07:30 PM	Abstract	054 - Salbutamol Increases SMN mRNA in Spinal Muscular Atrophy Patients (SMA): Relevance for Clinical Trial Design
03:00 PM - 07:30 PM	Abstract	055 - Further Progress in Defining UBE-1 Mutations and Downstream Effects Underlying X-Linked Lethal Infantile SMA (XL-SMA)
03:00 PM - 07:30 PM	Abstract	056 - Hand Held Dynamometry and Fixed Maximal Voluntary Isometric Contraction Strength Testing in Ambulatory Adults with Spinal Muscular Atrophy
03:00 PM - 07:30 PM	Abstract	057 - Biomarker Study for Spinal Muscular Atrophy: Study Design and Preliminary Results
03:00 PM - 07:30 PM	Abstract	058 - Videofluorography in Spinal and Bulbar Muscular Atrophy (SBMA)
03:00 PM - 07:30 PM	Abstract	059 - Reliability of the Six Minute Walk Test in Ambulatory Patients with Spinal Muscular Atrophy
03:00 PM - 07:30 PM	Abstract	060 - Fatigue Related Spatiotemporal Gait Changes during the Six Minute Walk Test in Spinal Muscular Atrophy (SMA)
03:00 PM - 07:30 PM	Abstract	061 - A Novel BSCL2/Seipin Variant Associated with Atypical Silver Syndrome Mimicking ALS
03:00 PM - 07:30 PM	Abstract	062 - Studies of Sequence Changes of the Dynactin p150 Gene In Vitro
03:00 PM - 07:30 PM	Abstract	063 - FUS Mutations in a Large Series of Sporadic and Familial ALS
03:00 PM - 07:30 PM	Abstract	064 - Fronto-Temporal Dementia in 3 ALS Families with TARDBP Missense Mutation
03:00 PM - 07:30 PM	Abstract	065 - The Mutational Spectrum of Adult Onset Dominant-Inherited Familial Amyotrophic Lateral Sclerosis in Chinese Population on Taiwan
03:00 PM - 07:30 PM	Abstract	066 - Initial Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS) - A Global Web-Based Registry
03:00 PM - 07:30 PM	Abstract	067 - Skin Denervation in Amyloid Neuropathy with a Hot-Spot Mutation of Transthyretin (Ala97Ser) in Taiwan
03:00 PM - 07:30 PM	Abstract	068 - Outcome Measures for Transthyretin Type Familial Amyloid Polyneuropathy
03:00 PM - 07:30 PM	Abstract	069 - Post-Liver Transplant ATTR Val30Met Patients: CNS Clinical Phenotype
03:00 PM - 07:30 PM	Abstract	070 - Transthyretin Familial Amyloid Polyneuropathy: Does a Mitochondrial Polymorphism Entirely Explain the Parent-of-Origin Difference in Penetrance?
03:00 PM - 07:30 PM	Abstract	071 - Patterns of Amyloid Deposition in Individual Patients with Mild Cognitive Impairment: An 11C-PIB PET Study
03:00 PM - 07:30 PM	Abstract	072 - Cortical Thickness Change in Alzheimer's Disease over 6 Months: Data from ADNI
03:00 PM - 07:30 PM	Abstract	073 - Can We Use Pons as a Reference Region for the Analysis of [11C]PIB PET?
03:00 PM - 07:30 PM	Abstract	074 - Florbetaben [beta]-Amyloid Brain PET - Correlation with Cognition Parameters in Alzheimer Disease
03:00 PM - 07:30 PM	Abstract	075 - Voxel-Based Longitudinal Changes of Gray Matter Density in Incipient Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	076 - In Cognitively Healthy and Mildly Impaired Individuals Florbetapir F 18 PET Measures of Amyloid Deposition Correlate with the Degree of Functional Impairment Assessed Six Months Later
03:00 PM - 07:30 PM	Abstract	077 - FDG-PET Pattern in Patients with White Matter Changes with and without Dementia: Differentiation from Alzheimer Disease
03:00 PM - 07:30 PM	Abstract	078 - Hippocampal Activation during Episodic Memory Processing in Healthy Adult Apolipoprotein E [epsilon]4 Carriers Is Significantly Influenced by Age
03:00 PM - 07:30 PM	Abstract	079 - The Changes of Cortical Gray Matter in Alzheimer's Disease According to Clinical Dementia Rating: Voxel Based Morphometric Study
03:00 PM - 07:30 PM	Abstract	080 - Progression of Prodromal AD Associated with Amyloid Deposition Using PIB PET Imaging
03:00 PM - 07:30 PM	Abstract	082 - Capgras Syndrome and the Cognitive Neuroscience of Attachment
03:00 PM - 07:30 PM	Abstract	083 - Diagnostic Serendipity in Evaluating Normal-Pressure Hydrocephalus
03:00 PM - 07:30 PM	Abstract	084 - Verbal Memory Decline in Alzheimer's Disease Is Associated with an Impairment of Frontal Executive Control
03:00 PM - 07:30 PM	Abstract	085 - Evidence That Cognitive Activities during Adulthood Modify the Reserve-Building Effects of ��ɫ��
03:00 PM - 07:30 PM	Abstract	086 - The Cognitive Reserve Reflected in Sex Differences Is Not Altered by APOE Genotype
03:00 PM - 07:30 PM	Abstract	087 - Micronutrients and Neuropsychologic Function in Patients with Mild Cognitive Impairment and Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	088 - Development of a Caregiver Burden Assessment in Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	089 - Assessing Differences in Co-Morbidities, Utilization, and Expenditures for Alzheimer's Medicare Beneficiaries Compared to the Non-Alzheimer's Medicare Population
03:00 PM - 07:30 PM	Abstract	090 - Clinically Confirmed Normal Pressure Hydrocephalus Usually Has Alzheimer's Disease Pathology at Autopsy
03:00 PM - 07:30 PM	Abstract	091 - Intranasal Insulin Modulates Hippocampal Activation According to APOE-[epsilon]4 Genotype in Early Alzheimer's Disease
03:00 PM - 07:30 PM	Abstract	092 - Age-Related Changes in Processing Syntactically Ambiguous Sentences: Evidence from fMRI
03:00 PM - 07:30 PM	Abstract	093 - Diagnostic Value of Presenting Symptoms and Physical Signs in Spinal Dural Arteriovenous Fistula
03:00 PM - 07:30 PM	Abstract	094 - The Northern Manhattan Study Global Vascular Risk Score Is Associated with Cognitive Performance
03:00 PM - 07:30 PM	Abstract	095 - Augmented Treatment Efficacy [mdash] A Repeated Measures Analysis of NINDS rt-PA Study
03:00 PM - 07:30 PM	Abstract	096 - Increased Expression of the Endocannabinoid Receptor 1 in Acute Human Stroke
03:00 PM - 07:30 PM	Abstract	097 - Ischemic Lesion Pattern Was Different According to Antithrombotic Treatment Status in Acute Cardioembolic Stroke
03:00 PM - 07:30 PM	Abstract	100 - Cephalocervical Aneurysms Associated with Fibromuscular Dysplasia
03:00 PM - 07:30 PM	Abstract	101 - Awareness of Stroke by Nigerians at High Risk
03:00 PM - 07:30 PM	Abstract	102 - Modafinil in Post Stroke Fatigue
03:00 PM - 07:30 PM	Abstract	103 - The Clinical Features of Late-Onset Poststroke Seizures
03:00 PM - 07:30 PM	Abstract	104 - Cocaine Strokes: Are Large Vessel Atherosclerosis and Small Vessel Disease More Prevalent Than Vasospasm?
03:00 PM - 07:30 PM	Abstract	105 - Are Stroke Prevention Measures Better Utilized in Primary Stroke Centers?
03:00 PM - 07:30 PM	Abstract	106 - Free-Floating Thrombus of the Carotid Artery Detected on Carotid Ultrasound in Patients with Cerebral Infarcts: A 10-Year Study
03:00 PM - 07:30 PM	Abstract	107 - Sex Differences in Acute Ischemic Stroke in the Young Adult Population
03:00 PM - 07:30 PM	Abstract	108 - Stroke Registry Definitions Lack Consensus across the US
03:00 PM - 07:30 PM	Abstract	109 - Factors Predictive of Length of Stay in Acute Ischemic Stroke Patients
03:00 PM - 07:30 PM	Abstract	110 - Incidence of Stroke and Stroke-Related Mortality on Ugandan Neurology Ward
03:00 PM - 07:30 PM	Abstract	111 - Barriers to Thrombolysis in Acute Ischaemic Stroke
03:00 PM - 07:30 PM	Abstract	112 - Concomitant Anterior Circulation Infarction and Age Correlate with Clinical Outcome in Posterior Circulation Strokes
03:00 PM - 07:30 PM	Abstract	113 - Currently Used Stroke Registry Definitions Have Poor Inter-Rater Reliability When Compared with ACC Guidelines
03:00 PM - 07:30 PM	Abstract	114 - Ischemic Stroke Due to Paradoxical Embolisms in the Hereditary Hemorrhagic Telangiectasia Disease: New Evidence for Repeated Screening and Early Treatment of Pulmonary Arteriovenous Malformations (PAVM). Study of 2 Cases and a Literature Review
03:00 PM - 07:30 PM	Abstract	115 - Aspirin Failure in Noncardioembolic Ischemic Stroke: A Retrospective Cohort Study on Its Incidence, Choice of Antiplatelet Treatment and Clinical Outcome
03:00 PM - 07:30 PM	Abstract	116 - Heart Rate Variability Changes Occur with MCA Stroke, Related to the Extent of Insular Ischemia
03:00 PM - 07:30 PM	Abstract	117 - TGF beta 1 and Acute Ischemic Stroke: The Protective Effect for Stroke Occurrence
03:00 PM - 07:30 PM	Abstract	118 - A Systems Approach to Stroke Care: The University Hospitals Cleveland Experience
03:00 PM - 07:30 PM	Abstract	119 - Acute Anticoagulation with Intravenous Un-Fractionated Heparin Reduces Early Recurrences in Cardio-Embolic Stroke
03:00 PM - 07:30 PM	Abstract	120 - Subclinical Tremor in Normal Controls with vs. without a Family History of Essential Tremor: Data from the United States and Turkey
03:00 PM - 07:30 PM	Abstract	121 - Increased Number of Heterotopic Purkinje Cells in Essential Tremor
03:00 PM - 07:30 PM	Abstract	122 - Holmes' Tremor: Etiology and Outcome - A Case Series of 37 Patients from the Mayo Clinic
03:00 PM - 07:30 PM	Abstract	123 - Embarrassment in Essential Tremor: Discrepancies between Patients and Neurologist-Experts
03:00 PM - 07:30 PM	Abstract	124 - Specificity of Purkinje Cell Loss in Essential Tremor
03:00 PM - 07:30 PM	Abstract	125 - Depressive Symptoms in Essential Tremor Patients
03:00 PM - 07:30 PM	Abstract	126 - Validity and Reliability of Computerized Tremor Spirography as Outcome Measure for Clinical Trials in Essential Tremor
03:00 PM - 07:30 PM	Abstract	127 - Long-Term Safety and Efficacy of Pramipexole Extended-Release in Early Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	128 - Long-Term Efficacy and Safety of Pramipexole Extended-Release in Advanced Parkinson's Disease: An Open-Label Trial
03:00 PM - 07:30 PM	Abstract	129 - Comparison of IPX066, a Novel Extended-Release Oral Carbidopa-Levodopa Formulation, to Immediate-Release Carbidopa-Levodopa in Patients with Advanced Parkinson's Disease (PD)
03:00 PM - 07:30 PM	Abstract	130 - Carbidopa/Levodopa Pharmacy Errors in Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	131 - Long-Term Treatment of Advanced Parkinson's Disease with Rotigotine
03:00 PM - 07:30 PM	Abstract	132 - Three-Year Efficacy and Safety Data for Ropinirole Prolonged Release in Patients with Early Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	133 - Open-Label Extension Trial Assessing the Effects of Long-Term Treatment with Rotigotine in Subjects with Early-Stage, Idiopathic Parkinson's Disease: Results from up to 7 Years
03:00 PM - 07:30 PM	Abstract	134 - 3,4-Dihydroxyphenylacetaldehyde Research Supports Rasagiline Neuroprotection Found in ADAGIO Study
03:00 PM - 07:30 PM	Abstract	135 - A 5-Year Prospective Assessment of Advanced Parkinson's Disease Patients Treated with Subcutaneous Apomorphine Infusion or Subthalamic Nucleus Deep Brain Stimulation
03:00 PM - 07:30 PM	Abstract	136 - Adverse Events and Patient Satisfaction Associated with Dopamine Agonist and Levodopa Use for RLS
03:00 PM - 07:30 PM	Abstract	137 - Parkinson's Disease and Idiopathic Restless Leg Syndrome
03:00 PM - 07:30 PM	Abstract	138 - Quantitative Assessment of Acute L-Dopa Effects on Parkinsonian Dysphagia with Videofluoroscopy
03:00 PM - 07:30 PM	Abstract	139 - Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease: Results from a Double-Blind, Sham-Controlled, Randomized, Controlled Trial
03:00 PM - 07:30 PM	Abstract	140 - Improvements in Awake Time Spent "On" throughout the Day in Patients with Advanced Parkinson's Disease Treated with Adjunctive Ropinirole Prolonged Release
03:00 PM - 07:30 PM	Abstract	141 - Utilizing Intensive-Amplitude Specific Therapeutic Approaches as an Effective Strategy for Improving Functional Mobility in Patients Diagnosed with Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	142 - Parkinson Movement Tests Performance: Effects of Acute Medication Challenge on Quantitative Measures in Standard Movement Tests
03:00 PM - 07:30 PM	Abstract	143 - Can Large Amplitude Exercise (ThinkBIG) and Nintendo Wii[reg] Game Exercise Offer Parkinson Disease Neuroprotection?
03:00 PM - 07:30 PM	Abstract	144 - Parkinson's Disease Patients: Owls or Larks
03:00 PM - 07:30 PM	Abstract	145 - Differential Response of Speed, Amplitude, and Rhythm to Dopaminergic Medications in Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	146 - Higher Proportion of Responders on the Clinical Global Impression - Improvement Scale with Ropinirole Prolonged Release Compared with Ropinirole Immediate Release in Patients with Advanced Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	147 - Improvements in Nocturnal Symptoms with Ropinirole Prolonged Release in Patients with Advanced Parkinson's Disease and with Significant Nocturnal Symptoms Not Optimally Controlled with L-Dopa
03:00 PM - 07:30 PM	Abstract	148 - Visuo-Motor Function in Patients with Parkinson's Disease Does Not Improve with Subthalamic Stimulation
03:00 PM - 07:30 PM	Abstract	149 - The National Deep Brain Stimulation Brain Tissue Network (DBS-BTN): Preliminary Results
03:00 PM - 07:30 PM	Abstract	150 - Brain Micro-Structural Features of Parkinsonian Signs in Very Old Persons: A Diffusion Tensor Imaging Study of the Health Aging and Body Composition (Health ABC) Cohort
03:00 PM - 07:30 PM	Abstract	151 - Cortico-Striatal Activity Patterns during a Finger-Movement fMRI Task in Parinson's Disease Patients On and Off Medication
03:00 PM - 07:30 PM	Abstract	152 - Deep Brain Stimulation Effects on Cardiovagal Responses in Patients with Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	153 - ADC Value of Substantia Nigra in Idiopathic Parkinson's Disease with Unilateral Motor Symptom
03:00 PM - 07:30 PM	Abstract	154 - Pallidal Stimulation in Advanced Parkinson's Patients with Contraindications for Subthalamic Stimulation
03:00 PM - 07:30 PM	Abstract	155 - Recognition Mismatch of Non-Motor Symptoms in DBS Candidates among Parkinson Patients and Caregivers May Be Scale Driven
03:00 PM - 07:30 PM	Abstract	156 - Lesion Rather Than Stimulation: Laterality of Microlesion Impacts Postoperative Verbal Fluency Decline in Subthalamic Deep Brain Stimulation Surgery
03:00 PM - 07:30 PM	Abstract	157 - Pediatric Deep Brain Stimulation at Cook Children's Medical Center: 22 Consecutive Cases
03:00 PM - 07:30 PM	Abstract	158 - The Unified Multiple System Atrophy Rating Scale (UMSARS) Is Also Suitable To Reveal the Progression of Chinese Multiple System Atrophy Patients
03:00 PM - 07:30 PM	Abstract	159 - Autopsy-Proven Progressive Supranuclear Palsy Presenting as Behavioral Variant Frontotemporal Dementia
03:00 PM - 07:30 PM	Abstract	160 - A Novel Mutation of CP Genes Inhibits Its Secretion and Causes Aceruloplasminemia
03:00 PM - 07:30 PM	Abstract	161 - Concordance for Wilson's Disease Phenotype among Siblings
03:00 PM - 07:30 PM	Abstract	162 - Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins: A Preliminary Report
03:00 PM - 07:30 PM	Abstract	163 - The Determinants of Disability in Corticobasal Syndrome
03:00 PM - 07:30 PM	Abstract	164 - Jaw-Opening Oromandibular Dystonia Secondary to Wilson's Disease - A Preliminary Report of 5 Cases after Use of Botulinum Toxin Type A
03:00 PM - 07:30 PM	Abstract	165 - Methyltetrahydrofolate Reductase Gene Polymorphism: A Novel Genetic Factor That Modifies Phenotypic Effects of Copper Toxicity in Wilson's Disease
03:00 PM - 07:30 PM	Abstract	166 - Aminopyridines Correct Presymptomatic Neuronal Dysfunction and Improve Late Behavioral and Cellular Phenotype in a Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)
03:00 PM - 07:30 PM	Abstract	167 - Zona Incerta Lesions Affect Striatal Neurochemistry and Behavioural Asymmetry in 6OHDA-Lesioned Rats
03:00 PM - 07:30 PM	Abstract	168 - Distinct Roles of GABAergic Interneurons in the Regulation of Striatal Output Pathways
03:00 PM - 07:30 PM	Abstract	170 - Post-Mortem Neurochemical Evidence for Decreased Putamen Aldehyde Dehydrogenase in Parkinson Disease
03:00 PM - 07:30 PM	Abstract	171 - SEP-228791, a Novel Dopamine and Norepinephrine Re-Uptake Inhibitor, Has Anti-Parkinsonian Actions, without Eliciting Dyskinesia, in the MPTP-Lesioned Primate Model of Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	172 - Neurodegenerative Markers in CSF in Patients Suffering from Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	173 - Apathy in Multiple Sclerosis and Its Association with Depression, Fatigue and Cognitive Impairment
03:00 PM - 07:30 PM	Abstract	174 - Episodic Memory in a Cohort of 395 Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	175 - A Novel Computerized Word-Naming Test Shows That Crossed-Hemisphere Processing Speed Is Slowed in Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	176 - Cognitive and Psychosocial Evaluation of Patients with Benign Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	177 - Ten-Year Trends by Patient-Report Metrics in Multiple Sclerosis Functional and Psychosocial Limitations
03:00 PM - 07:30 PM	Abstract	178 - Depression and Fatigue in Clinically Definite Multiple Sclerosis (CDMS, McDonald Criteria) - Results from the Oregon Multiple Sclerosis Registry (OMSR)
03:00 PM - 07:30 PM	Abstract	179 - Multiple Sclerosis: EDSS and Disease Duration: Effects on Cognition in a Community Based Study
03:00 PM - 07:30 PM	Abstract	180 - Cognitive Impairment in Patients with Clinically Isolated Syndrome: A Reappraisal after 8 Years
03:00 PM - 07:30 PM	Abstract	181 - Group Psychotherapy in Patients with Multiple Sclerosis: A Six-Months Study in Groups with Different Disability Scores
03:00 PM - 07:30 PM	Abstract	182 - Longitudinal Changes on Self-Report of Cognitive Symptoms on the Perceived Deficits Questionnaire in MS: Correlations with Changes in Neuropsychologic Tests and Depression
03:00 PM - 07:30 PM	Abstract	183 - Estimating the Probability of Employment Status Transitions and Exploration of Influential Factors
03:00 PM - 07:30 PM	Abstract	184 - Hand Function, Mobility, and Employment Status in the NARCOMS Registry
03:00 PM - 07:30 PM	Abstract	185 - Ipsilateral Motor Cortex Activity in RRMS: Compensation or Not?
03:00 PM - 07:30 PM	Abstract	186 - Pregnancy Outcomes from the AVONEX[reg] (Interferon beta-1a) Pregnancy Exposure Registry
03:00 PM - 07:30 PM	Abstract	187 - An Assessment of Bone Health Lifestyle Factors in MS Patients
03:00 PM - 07:30 PM	Abstract	188 - Lack of Congruence in the Ratings of Patients' Health Status by Patients with Multiple Sclerosis and Their Physicians
03:00 PM - 07:30 PM	Abstract	189 - Impact of Treatment Adherence on Clinical and Economic Outcomes among Multiple Sclerosis Patients Receiving Disease-Modifying Therapies
03:00 PM - 07:30 PM	Abstract	190 - Headache in Multiple Sclerosis. Clinical and Therapeutical Correlations
03:00 PM - 07:30 PM	Abstract	191 - Spectrum of Clinical Symptoms in Early MS with Pathologically-Confirmed Cortical Demyelination
03:00 PM - 07:30 PM	Abstract	192 - Increasing Macroscopic Pathological Damage in Multiple Sclerosis (MS) Is Associated with More Severe Disease Milestones
03:00 PM - 07:30 PM	Abstract	193 - Changes in Circulating Tregs Parallel Reductions in Activated T Cells during Daclizumab Treatment of MS
03:00 PM - 07:30 PM	Abstract	194 - Hypereosinophilia with Natalizumab
03:00 PM - 07:30 PM	Abstract	195 - In MS Patients, When Should MxA mRNA Be Measured after Interferon-beta Injections?
03:00 PM - 07:30 PM	Abstract	196 - Differential Effects of a Selective Sphingosine 1-Phosphate Receptor 1 (S1P1) Modulator (CS-0777) on Circulating Lymphocyte Subsets in Multiple Sclerosis Patients
03:00 PM - 07:30 PM	Abstract	197 - Interferon Beta-1a Modulation of B Cells: Implications for Relapsing Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	198 - Effects of Glatiramer Acetate on Proliferation and Differentiation of OLN-93 Cells and Its Interaction with FGF2
03:00 PM - 07:30 PM	Abstract	199 - Unusual Development of Progressive Multifocal Leukoencephalopathy with High JC Virus Titer in a Patient with Multiple Sclerosis after 2 Years of Natalizumab Therapy
03:00 PM - 07:30 PM	Abstract	200 - In Vitro Whole Blood Monitoring of Biological Response to Type I Interferon Therapy in Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	201 - Intravenous Immunoglobulin (IVIG) in Treatment of Central Pontine and Extrapontine Myelinolysis
03:00 PM - 07:30 PM	Abstract	202 - An IL-2 Paradox; Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
03:00 PM - 07:30 PM	Abstract	203 - P2X7 Purinergic Receptor on Monocytes of Patients with Multiple Sclerosis: Effects of Glatiramer Acetate Immune Modulation
03:00 PM - 07:30 PM	Abstract	204 - Treatment Effects of IFNB-1b on Cognitive Performance in Patients with a First Event Suggestive of MS
03:00 PM - 07:30 PM	Abstract	205 - CD161/CCR6 (IL-17 Associated) Expression in Relapsing MS: Effect of Glatiramer Acetate on Immune Regulation
03:00 PM - 07:30 PM	Abstract	206 - Systematic Assessment of JC Virus in Multiple Sclerosis Patients Treated with Natalizumab
03:00 PM - 07:30 PM	Abstract	207 - Pharmacokinetics of Oral BG-12 Alone Compared with BG-12 and Interferon [beta]-1a or Glatiramer Acetate Administered Together, Studied in Healthy Volunteers
03:00 PM - 07:30 PM	Abstract	208 - Laquinimod In Vitro High-Throughput Gene Analysis Reveals Orchestrated Th2 Shift in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	209 - Omega-3 Fatty Acids Treatment in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	210 - Duration Following Severe Attacks of CNS Demyelinating Disease to Plasma Exchange Initiation: How Long Is Too Long?
03:00 PM - 07:30 PM	Abstract	211 - Safety and Efficacy of Autologous T-Cell Immunotherapy (Tovaxin) in Patients with Active Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	212 - Synergistic Mechanisms of Fumarate Treatment in CNS Autommunity: Augmenting Axon Protective Effects in Combination Therapies
03:00 PM - 07:30 PM	Abstract	213 - Alemtuzumab Reduces Disease Progression in RRMS: Long-Term Results of the CAMMS223 Trial
03:00 PM - 07:30 PM	Abstract	214 - Prediction and Characterization of CD56bright NK Cell Expansion during Daclizumab Treatment for Multiple Sclerosis
03:00 PM - 07:30 PM	Abstract	215 - Multiple Sclerosis and Other CNS Demyelination after Treatment with Tumor Necrosis Factor alpha Blockers
03:00 PM - 07:30 PM	Abstract	216 - Copolymer-1 Shows Neuroprotective Effects Via Peripheral Immunomodulation Rather Than Direct Actions on Neurons
03:00 PM - 07:30 PM	Abstract	217 - Cellular and Humoral Influenza Vaccine-Specific Immune Responses in Patients with Multiple Sclerosis Treated with FTY720 or Interferon-beta
03:00 PM - 07:30 PM	Abstract	218 - Production of Neurotrophic Factors in MS Patients Treated with Disease Modifying Therapies
03:00 PM - 07:30 PM	Abstract	219 - Effects of Cladribine Tablets on Circulating Lymphocyte Subset Reconstitution in the 96-Week CLARITY Study in Relapsing-Remitting Multiple Sclerosis (RRMS)
03:00 PM - 07:30 PM	Abstract	220 - Plasmacytoid Denditic Cells (pDC) in Multiple Sclerosis: IFN-[beta] Treatment Inhibits pDC Secretion of Chemokines Specific for CCR5-Positive Th1 Cells
03:00 PM - 07:30 PM	Abstract	221 - Decreased Chemokine Directed Migration of Effector Memory T Cells in Fingolimod-Treated Patients
03:00 PM - 07:30 PM	Abstract	222 - The Activation of Microglia and Macrophages Is Attenuated by Laquinimod
03:00 PM - 07:30 PM	Abstract	223 - Glatiramer Acetate-Reactive T Lymphocytes Regulate Oligodendrocyte Progenitor Cell Number In Vitro
03:00 PM - 07:30 PM	Abstract	224 - Predictors of Ventricular Volume in HIV Disease
03:00 PM - 07:30 PM	Abstract	225 - Dual Infection with HIV and HCV Has Worse Effects on Cognition Than Infection with HIV Alone
03:00 PM - 07:30 PM	Abstract	226 - Utility of HIV-Associated Neuropathy Screening Tools in Western Kenya: Pilot Testing
03:00 PM - 07:30 PM	Abstract	227 - Validation of a Novel Computerized Performance-Based Functional Assessment for HIV Associated Neurocognitive Disorders
03:00 PM - 07:30 PM	Abstract	228 - Clinical and Cognitive Associations with Midsagittal Corpus Callosum Area in HIV Infected Patients
03:00 PM - 07:30 PM	Abstract	230 - Matrix Metalloproteinase-1 Protects Against HIV-1 Tat-Induced Neurotoxicity by Cleavage-Dependent and Cleavage-Independent Mechanisms
03:00 PM - 07:30 PM	Abstract	231 - Atrophy in the Medial Temporal Lobes of HIV Patients Is Correlated to ADC Stage
03:00 PM - 07:30 PM	Abstract	232 - Gray Matter Volume Loss in HIV Associated Dementia
03:00 PM - 07:30 PM	Abstract	233 - Mechanisms of Neurotoxicity Induced by Morphine in the HIV-1 Transgenic Rat
03:00 PM - 07:30 PM	Abstract	234 - Utility of a Diagnostic Tool for HIV-Associated Cognitive Impairment in Western Kenya: Pilot Testing
03:00 PM - 07:30 PM	Abstract	235 - Pattern of Neuropsychological Performance among HIV-Positive Patients in Kenya
03:00 PM - 07:30 PM	Abstract	236 - Prevalence of Seizures in HIV Patients Measured in the Outpatient Setting
03:00 PM - 07:30 PM	Abstract	237 - CNS Immune Reconstitution Inflammatory Syndrome (IRIS) in an HIV-Infected Patient with a Stable CD4 Cell Count and Undetectable Viral Load
03:00 PM - 07:30 PM	Abstract	238 - Prevalence of HTLV-1 among Selected Cases of Progressive Spastic Non-Compressive Myelopathy in North-Eastern Nigeria
03:00 PM - 07:30 PM	Abstract	239 - Progression of Nerve Conduction and EMG Abnormalities in Acute West Nile Virus Infection
03:00 PM - 07:30 PM	Abstract	240 - Factors Governing Herpes Simplex Virus Type 1 (HSV-1) Infection of Brain Tissues in Organotypic Cultures
03:00 PM - 07:30 PM	Abstract	241 - Encephalitis Associated with Pandemic H1N1-2009: Case Report and Review
03:00 PM - 07:30 PM	Abstract	242 - Novel H1N1 Encephalomyelitis
03:00 PM - 07:30 PM	Abstract	243 - High Cervical Cord Injury with Posterior Reversible Leukoencephalopathy Syndrome: Case Report
03:00 PM - 07:30 PM	Abstract	244 - Focal Hyperhidrosis Due to Irritative Effect of Nerve Root and Spinal Cord Mass Lesions
03:00 PM - 07:30 PM	Abstract	245 - Underlying Autonomic Dysfunction in Cough Syncope
03:00 PM - 07:30 PM	Abstract	246 - Comorbid Health Conditions in Women with Syncope
03:00 PM - 07:30 PM	Abstract	247 - Can Sex Hormone Dysregulation Cause Autonomic Storm?
03:00 PM - 07:30 PM	Abstract	248 - The Identification and Characterization of Autonomic Dysfunction in Migraineurs with and without Auras
03:00 PM - 07:30 PM	Abstract	249 - Orthostatic and Non-Orthostatic Headache in Postural Tachycardia Syndrome (POTS)
03:00 PM - 07:30 PM	Abstract	250 - Menstrual Symptom Alteration in Orthostatic Intolerance, Syncope, and Migraine
03:00 PM - 07:30 PM	Abstract	251 - Pregnancy in Postural Tachycardia Syndrome: Clinical Course and Maternal and Fetal Outcomes
03:00 PM - 07:30 PM	Abstract	252 - Psychogenic Non-Epileptic Seizures in Postural Orthostatic Tachycardia Syndrome
03:00 PM - 07:30 PM	Abstract	253 - Low Iron Storage and Anemia in Adolescents with Postural Tachycardia Syndrome (POTS)
03:00 PM - 07:30 PM	Abstract	254 - What Is the Optimal Duration of a Tilt Table Test?
03:00 PM - 07:30 PM	Abstract	255 - Cardiac Metaiodobenzylguanidine (cMIBG) Scintigraphy Is a Useful Tool To Access Subclinical Autonomic Involvement in Peripheral Neuropathies
03:00 PM - 07:30 PM	Abstract	256 - Catecholaminergic Denervation in the Brain and Heart in Parkinson Disease: Associations with Non-Motor Manifestations
03:00 PM - 07:30 PM	Abstract	257 - A Modification to the Quantitative Direct and Indirect Axon Reflex Sudomotor Test (QDIRT) Enhances Test Utility
03:00 PM - 07:30 PM	Abstract	258 - Treatment Induced Diabetic Neuropathy - An Acute Reversible Painful Autonomic Neuropathy
03:00 PM - 07:30 PM	Abstract	259 - Contamination of the Norepinephrine Pro-Drug Droxidopa by Dihydroxyphenylacetaldehyde
03:00 PM - 07:30 PM	Abstract	260 - Pleasant Olfactory Stimulation Enhances Cardiovagal Modulation in Mild Traumatic Brain Injury Patients
03:00 PM - 07:30 PM	Abstract	261 - Hematopoietic Cell Transplantation for Adolescent-Onset Cerebral X-Linked Adrenoleukodystrophy
03:00 PM - 07:30 PM	Abstract	262 - Prevalence of Somatic and Autonomic Small Fiber Neuropathy in a Cohort of Patients with Inflammatory Bowel Disease (IBD)
03:00 PM - 07:30 PM	Abstract	263 - Menstrual Exacerbation in Irritable Bowel Syndrome, Fibromyalgia and Interstitial Cystitis
03:00 PM - 07:30 PM	Abstract	264 - Prospective Elderly Human Blood-CNS Biodistribution and Neurocognitive Studies of a Quaternary Amine Antimuscarinic Agent for Overactive Bladder (OAB): The SMART Trial
03:00 PM - 07:30 PM	Abstract	265 - Self-Complementary AAV Induces Rapid and Highly Efficient Allotopic Expression of the Human ND4 Complex I Subunit in the Mouse Visual System
03:00 PM - 07:30 PM	Abstract	266 - Idiopathic Intracranial Hypertension at a Canadian Tertiary Care Centre
03:00 PM - 07:30 PM	Abstract	267 - Neuroretinitis with Bartonella Henselae and EBV Co-Infection: Direct Infection or Immunomodulated Reaction?
03:00 PM - 07:30 PM	Abstract	268 - Obstructive Sleep Apnea (OSA) in Idiopathic Intracranial Hypertension (IIH): A Prospective Study
03:00 PM - 07:30 PM	Abstract	269 - Neuro-Ophthalmological Implications of CADASIL
03:00 PM - 07:30 PM	Abstract	270 - Short Term Adaptation of Visual Search Strategies in Simulated Hemianopia
03:00 PM - 07:30 PM	Abstract	271 - Region-Specific Patters of White Matter Diffusivity Changes in Leber's Hereditary Optic Neuropathy: A Tract-Based Spatial Statistics Study
03:00 PM - 07:30 PM	Abstract	272 - Retinal Nerve Fibre Layer Thickness and Brain Volume in Acute Optic Neuritis
03:00 PM - 07:30 PM	Abstract	273 - Anemia-Dependent Transient Cortical Visual Loss Heralding Acute Myelogenous Leukemia in a Woman with Basilar Stenosis
03:00 PM - 07:30 PM	Abstract	274 - Optical Coherence Tomography as Measure of the Effects of Glatiramer Acetate on Axonal Loss in Patients with Acute Optic Neuritis (AON)
03:00 PM - 07:30 PM	Abstract	275 - Is Down Slower Than Up? Vertical Saccades in Progressive Supranuclear Palsy (PSP)
03:00 PM - 07:30 PM	Abstract	276 - The Usefulness of Bedside Neuro-Otological Examination in Differentiating Central and Peripheral Causes of Isolated Vertigo in Emergency Room
03:00 PM - 07:30 PM	Abstract	277 - Vestibular Evoked Neurogenic Potentials Using Air-Conducted Sound: The Discovery of a New Scalp Recorded Potential (N6) That Probably Originates from the Midbrain
03:00 PM - 07:30 PM	Abstract	278 - Vestibular Dysfuctions in Migrainous Vertigo Evaluated by Rotatory Chair
03:00 PM - 07:30 PM	Abstract	279 - Horizontal Conjugate Gaze Deviation in the Acute Vestibular Syndrome
03:00 PM - 07:30 PM	Abstract	280 - Bilateral Synergistic Convergence with Horizontal Gaze Palsy and Scoliosis. Is the Mechanism Supranuclear?
03:00 PM - 07:30 PM	Abstract	281 - The Video Head Impulse Test: Diagnostic Accuracy in Peripheral Vestibulopathy
03:00 PM - 07:30 PM	Abstract	282 - Acute Encephalopathy, Multiple Ocular Motor Deficits and Bilateral Ptosis Following Embolization of Branches of the External Carotid Artery Feeding a Carotid Body Tumor
03:00 PM - 07:30 PM	Abstract	283 - Prosaccade and Antisaccade Performances in Spinocerebellar Ataxia Type 2 and Other Genetic Ataxias
03:00 PM - 07:30 PM	Abstract	284 - Cerebral Hemispheric Eye Movement Disorders Are Different in Parkin-Linked and Idiopathic Parkinson's Disease
03:00 PM - 07:30 PM	Abstract	285 - Recurrence of Symptoms after Successful Carotid Cavernous Fistula Endovascular Treatment
03:00 PM - 07:30 PM	Abstract	286 - The m.3244G[gt]A Mutation in mtDNA Is Another Cause of Progressive External Ophthalmoplegia
03:00 PM - 07:30 PM	Abstract	287 - Saccadic Abnormalities in Ocular Myasthenia Reflect Morphological Differences between Neuromuscular Junctions of Extraocular Muscle-Fiber Types
03:00 PM - 07:30 PM	Abstract	288 - Prevalence of Clinical Neuro-Ophthalmic Abnormalities in an ALS Cohort
03:00 PM - 07:30 PM	Abstract	289 - Ocular Myositis in Crohn's Disease with MRI Imaging Mimicking Thyroid Ophthalmopathy
03:00 PM - 07:30 PM	Abstract	290 - Saccade Related Gamma Oscillations Recorded from the Human Basal Ganglia and Thalamus Originate from Ocular Muscles

Faculty Disclosures
Barry D. Jordan, MD	Dr. Jordan has nothing to disclose.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Jason Barton, MD, PhD, FRCPC	The institution of Dr. Barton has received research support from Canada research Chair. Dr. Barton has received publishing royalties from a publication relating to health care. Dr. Barton has received personal compensation in the range of $500-$4,999 for serving as a guideline for vision therapy in MTBI with ICBC.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Mark Hallett, MD, FAAN	Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
J. D. Bartleson, MD, FAAN	Dr. Bartleson has nothing to disclose.
Grant Liu, MD, FAAN	Dr. Liu has received publishing royalties from a publication relating to health care.
Stephen D. Silberstein, MD, FAAN	Dr. Silberstein has received publishing royalties from a publication relating to health care.
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical ��ɫ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' ��ɫ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical ��ɫ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research ��ɫ�� Social Awareness and Training In Neurosciences.
William P. Cheshire, Jr., MD, FAAN	Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities.
Nancy J. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.
Penelope Hogarth, MD	No disclosure on file
Kirk R. Daffner, MD, FAAN	The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Joanna C. Jen, MD, PhD	Dr. Jen has nothing to disclose.
Bahram Mokri, MD	No disclosure on file
Phyllis C. Zee, MD, PhD	Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for World Sleep Society. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Brain Foundation. An immediate family member of Dr. Zee has stock in Teva. An immediate family member of Dr. Zee has stock in Pfizer. The institution of Dr. Zee has received research support from National Institutes of Health. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Burk Jubelt, MD	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Shashidhar Kori, MD	Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Daniel Kaufer, MD, FAAN	No disclosure on file
Vladimir Hachinski, MD, DSc, FAAN	Dr. Hachinski has nothing to disclose.
Valerie Biousse, MD	Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
David E. Riley, MD	Dr. Riley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Joseph E. Parisi, MD	Dr. Parisi has nothing to disclose.
Elan D. Louis, MD, MS, FAAN	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Jau-Shin Lou, MD, PhD, FAAN	Dr. Lou has nothing to disclose.
David H. Miller, MD, MBChB, FRCP	No disclosure on file
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Israel Steiner, MD	No disclosure on file
Ruth H. Whitham, MD, FAAN	No disclosure on file
Ray L. Watts, MD, FAAN	No disclosure on file
Richard M. Ransohoff, MD	Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
Lisa L. Baumbach-Reardon, PhD, FACMG	No disclosure on file
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Justin C. McArthur, MBBS, MPH, FAAN	No disclosure on file
Patrick Pullicino, MD	No disclosure on file
Eduardo E. Benarroch, MD, FAAN	Dr. Benarroch has nothing to disclose.
Mark J. Kupersmith, MD, FAAN	Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
Robert B. Daroff, MD, FAAN	No disclosure on file
Jack P. Antel, MD, FAAN	Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Howard A. Crystal, MD, FAAN	An immediate family member of Dr. Crystal has received personal compensation for serving as an employee of C4 TherAPEUTICS. An immediate family member of Dr. Crystal has stock in c4 THERAPEUTICS. Dr. Crystal has stock in c4 THERAPEUTICS.
Michael G. Halmagyi, MD	Dr. Halmagyi has nothing to disclose.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Anthony J. Furlan, MD, FAAN	No disclosure on file
David S. Goldstein, MD, PhD	Dr. Goldstein has received publishing royalties from a publication relating to health care.
Fatta B. Nahab, MD, FAAN	Dr. Nahab has received personal compensation for serving as an employee of Neuron23. Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ActualSignal. Dr. Nahab has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Attune Neurosciences, Inc.. Dr. Nahab has stock in Biogen. Dr. Nahab has received personal compensation in the range of $500-$4,999 for serving as a DSMB Member with NIH.
Brendan J. Kelley, MD, FAAN	Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Stefan Schwab, MD	Dr. Schwab has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Wendy M. King, PT	Ms. King has nothing to disclose.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey Rumbaugh, MD	No disclosure on file
Nancy L. Sicotte, MD, FAAN	The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
Max J. Hilz, MD, PhD, FAAN	Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Patrick M. Grogan, MD, FAAN	No disclosure on file
Ruth H. Walker, PhD, MB, ChB	Dr. Walker has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc, Inc.. The institution of Dr. Walker has received research support from Department of Veterans Affairs.
Thomas C. Chelimsky, MD	Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Leo McCluskey, MD	No disclosure on file
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Ana-Luiza Sayao, MD	Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Serono. Dr. Sayao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Kristi M. Nord, MD	No disclosure on file
Edmond Teng, MD, PhD	Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Martin Berghoff, MD, FAAN	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Andrew P. Duker, MD	No disclosure on file
Brian Grosberg, MD	Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Beau B. Bruce, MD, FAAN	Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
Mark F. Lew, MD, FAAN	Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Melissa J. Nirenberg, MD, PhD, FAAN	The institution of Dr. Nirenberg has received research support from Department of Veterans Affairs,. The institution of Dr. Nirenberg has received research support from National Institutes of Health. Dr. Nirenberg has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson's Foundation.
Cindy Zadikoff, MD	Dr. Zadikoff has received personal compensation for serving as an employee of AbbVie.
Margaret Park, MD	No disclosure on file
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Sandra E. Black, MD, FAAN	Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Jorge C. Kattah, MD, FAAN	Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Seymour Solomon, MD, FAAN	No disclosure on file
Tanis J. Ferman, PhD	Ms. Ferman has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Massimo Pandolfo, MD, FAAN	Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.
Jerzy P. Szaflarski, MD, PhD, FAAN	Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Ali H. Rajput, MD, FAAN	No disclosure on file
Teresa J. Buracchio, MD	No disclosure on file
Jason S. Hawley, MD	Dr. Hawley has nothing to disclose.
Mark J. Tullman, MD	Dr. Tullman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Tullman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viela Bio.
Mamatha Pasnoor, MD, FAAN	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Jun Xu, MD	No disclosure on file
Miguel Bussiere, MD, PhD	No disclosure on file
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
	No disclosure on file
Nereo Bresolin, DR	No disclosure on file
Fernando Acosta, MD	No disclosure on file
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Savvas S. Papacostas, DO, FAAN	No disclosure on file
Bing-Wen Soong, MD, PhD, FAAN	No disclosure on file
Yi-Chung Lee, MD, FAAN	The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Iftekhar Ahmed, MD, PC, FAAN	Dr. Ahmed has nothing to disclose.
Brigitte Stemper, MD	No disclosure on file
Peter P. Pramstaller, MD	No disclosure on file
Matthias Maschke, MD	No disclosure on file
Robert D. Fealey, MD	No disclosure on file
James E. Galvin, MD, MPH	Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Helio Afonso G. Teive, MD, PhD, FAAN	Dr. Teive has nothing to disclose.
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Katherine P. Rankin, PhD	The institution of Dr. Rankin has received research support from Marcus Foundation.
George J. Hutton, MD, FAAN	Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Allyson Zazulia	An immediate family member of Dr. Zazulia has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care Society.
Peter A. LeWitt, MD	Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Rivka Inzelberg, MD	No disclosure on file
Claudio Mariani, MD	No disclosure on file
Alexander H. Rajput, MD, FAAN	Dr. Rajput has received personal compensation in the range of $500-$4,999 for serving as a Peer reviewer with CQDM.
Michele L. Rajput	No disclosure on file
Youn Young Chul, MD	No disclosure on file
Gabriele Mora, MD	Dr. Mora has nothing to disclose.
Fabrizio Salvi, MD	No disclosure on file
Ola A. Selnes, PhD	No disclosure on file
Ned C. Sacktor, MD, FAAN	No disclosure on file
Richard L. Skolasky, BA	No disclosure on file
Victor Valcour, MD	Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IAS-USA. Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Paola Tortorella	No disclosure on file
Anna Feldman	No disclosure on file
Michael Gurevich	No disclosure on file
Gary Hunter, MD	No disclosure on file
Miguel J. Lainez, MD, PhD, FAAN	No disclosure on file
Arshad Majid, MD	Dr. Majid has received publishing royalties from a publication relating to health care.
Mounzer Kassab, MD	No disclosure on file
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Giuseppe Lanzino, MD	Dr. Lanzino has nothing to disclose.
Richard Levy	Richard Levy has nothing to disclose.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Anna D. Hohler, MD, FAAN	Dr. Hohler has nothing to disclose.
John Pula, MD, FAAN	Dr. Pula has nothing to disclose.
Gilles Edan, MD	No disclosure on file
Howard Aizenstein, MD, PhD	No disclosure on file
James T. Becker, PhD	No disclosure on file
Caterina Rosano, MD, MPH	No disclosure on file
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Bennett L. Lavenstein, MD, FAAN	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Stefania Corti, MD, PhD	Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Dawn McGuire, MD, FAAN	No disclosure on file
Ja-Seong Koo, MD	No disclosure on file
Jong-Moo Park, MD	No disclosure on file
Ohyun Kwon	No disclosure on file
Kelly D. Foote, MD	Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Alan Lerner, MD	The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Laurence J. Kinsella, MD, FAAN	Dr. Kinsella has received publishing royalties from a publication relating to health care.
Mario F. Mendez, MD, PhD, FAAN	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical ��ɫ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Ramesh Khurana, MD, FAAN	No disclosure on file
Frederic Assal, MD	Dr. Assal has nothing to disclose.
Raphael Hourez, MD, PhD	No disclosure on file
Laurent Servais	Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Carol Moore	No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Leonard Verhagen Metman, MD, PhD	Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Vanessa Troiani	No disclosure on file
Ann F. Hsu, PhD, PharmD	No disclosure on file
Sarah Pirio Richardson, MD, FAAN	Dr. Pirio Richardson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Pirio Richardson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. The institution of Dr. Pirio Richardson has received research support from NIH. The institution of Dr. Pirio Richardson has received research support from DOD. The institution of Dr. Pirio Richardson has received research support from Scion. The institution of Dr. Pirio Richardson has received research support from Jazz Pharmaceuticals. The institution of Dr. Pirio Richardson has received research support from UCB. The institution of Dr. Pirio Richardson has received research support from Buk-wang Pharmaceuticals.
Bruce R. Reed, PhD	No disclosure on file
Goran Rakocevic, MD, FAAN	Dr. Rakocevic has nothing to disclose.
Violaine Plante-Bordeneuve, MD	Dr. Plante-Bordeneuve has nothing to disclose.
Aninda Acharya, MD	Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Acharya has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Acharya has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Angel Golimstok	No disclosure on file
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Chris H. Polman, MD	No disclosure on file
Anthony Schapira	No disclosure on file
Kallol R. Chaudhuri, MD, FRCP	Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Fabrizio Stocchi	Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
JeeHyun Kwon, MD	No disclosure on file
Rupert Sandbrink, MD, PhD	Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Christoph Pohl, MD	No disclosure on file
Daniel R. Wynn, MD	Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Angelo Quartarone, MD	No disclosure on file
Eugene C. Lai, MD, PhD, FAAN	Dr. Lai has received publishing royalties from a publication relating to health care.
Vera Novak, MD	No disclosure on file
Stewart H. Mostofsky, MD	No disclosure on file
Clyde E. Markowitz, MD	No disclosure on file
Panayiotis Mitsias, MD	The institution of Dr. Mitsias has received research support from European Union.
Paul Edison, MBBS, PhD, FRCPI	No disclosure on file
Sean S. O'Sullivan, MD	No disclosure on file
Laura Herbelin	No disclosure on file
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Ayse Altintas, MD	Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Ioannis U. Isaias, MD	Dr. Isaias has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Newronika. Dr. Isaias has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Isaias has stock in Newronika. Dr. Isaias has received research support from Fondazione Grigioni per il Morbo di Parkinson. The institution of Dr. Isaias has received research support from Fresco Parkinson Institute Italia Onlus. The institution of Dr. Isaias has received research support from Deutsche Forschungsgemeinschaft.
Yang Mao-Draayer, MD	Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Jacqueline Channon-Smith	No disclosure on file
William J. Burke, MD, PhD, FAAN	No disclosure on file
Vijay B. Kumar	No disclosure on file
W. Michael Panneton, PhD	No disclosure on file
Shanu Roemer	Shanu Roemer has nothing to disclose.
Erdem Tuzun	Erdem Tuzun has nothing to disclose.
Joanna Hellmuth, MD	Dr. Hellmuth has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McAngus Goudelock & Courie law firm.
Andreas J. Plaitakis, MD	No disclosure on file
Oren S. Cohen, MD	No disclosure on file
Sharon Hassin-Baer, MD	Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Martin Nevrly, MD	No disclosure on file
Myeong-Kyu Kim	No disclosure on file
Seung-Han Lee, MD, PhD	Dr. Lee has nothing to disclose.
Caroline Bensa	Caroline Bensa has nothing to disclose.
M.T. Dotti, MD	No disclosure on file
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Per Soelberg Sorensen	No disclosure on file
Olivier Rascol, MD, PhD	Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Richard P. Allen, PhD	No disclosure on file
Eric Roy, PhD	No disclosure on file
Hisatomo Kowa, MD, PhD	No disclosure on file
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
David G. Munoz, MD	No disclosure on file
Dan M. Mungas, PhD	Dr. Mungas has nothing to disclose.
Andrew J. Lees, MD, FRCP	Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma.
Richard T. Benson, MD, PhD, FAAN	Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journals (AAN). Dr. Benson has received personal compensation in the range of $100,000-$499,999 for serving as a Federal employee with HHS/NIH.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Petra Kaufmann, MD, FAAN	Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to AAN interests or activities.
Jacqueline Montes, PT, EdD, NCS	Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Joel J. Oger, MD, FRCPC, FAAN	No disclosure on file
Wolfgang Heide, MD, FEAN	No disclosure on file
Bruce A. Cohen, MD, FAAN	Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. The institution of Dr. Cohen has received research support from Genentech. The institution of Dr. Cohen has received research support from MedDay. The institution of Dr. Cohen has received research support from Consortium of Multiple Sclerosis Centers.
Raija Lindberg, MD	No disclosure on file
Mustafa Ertas	No disclosure on file
Andreas Straube	Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis.
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has nothing to disclose.
Jyh-Gong G. Hou, MD, PhD, FAAN	No disclosure on file
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Kathryn J. Swoboda, MD	Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
Viviane H. Zetola, MD	Dr. Zetola has nothing to disclose.
Tonette Gehrking	Tonette Gehrking has nothing to disclose.
Jacob S. Elkins, MD	No disclosure on file
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
David A. Bennett, MD	Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Neil Cherian, MD	Dr. Cherian has nothing to disclose.
Pinky H. Agarwal, MD, FAAN	Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Vera Fridman, MD	Dr. Fridman has nothing to disclose.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Michael W. Lenihan, MD	No disclosure on file
David H. Snyder, MD	No disclosure on file
Cornelia Mihai, MD, FAAN	Dr. Mihai has nothing to disclose.
Seth A. Smith, PhD	Dr. Smith has nothing to disclose.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Robert C. Sergott, MD	Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
William J. Triggs, MD	No disclosure on file
Susan Roberson, RN	No disclosure on file
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Sun U. Kwon, MD	No disclosure on file
Dong-wha Kang, MD	No disclosure on file
Jennifer Michaels, MD	No disclosure on file
Alida F. Griffith, MD	No disclosure on file
Ju-Hun Lee, MD	No disclosure on file
Lucas Restrepo, MD, PhD	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Sushant P. Kale, MD	No disclosure on file
David B. Rye, MD, PhD	No disclosure on file
Bryan K. Woodruff, MD	The institution of Dr. Woodruff has received research support from National Institute on Aging.
Steven K. Feske, MD	Dr. Feske has received publishing royalties from a publication relating to health care.
Maria V. Alvarez, MD	No disclosure on file
Dana H. Gabuzda, MD	Dr. Gabuzda has nothing to disclose.
David E. Newman-Toker, MD, PhD, FAAN	The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Joseph Y. Matsumoto, MD	Dr. Matsumoto has nothing to disclose.
Jesus Lovera, MD	Dr. Lovera has nothing to disclose.
Juha O. Rinne, MD, PhD	No disclosure on file
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Susan Fox, MD, FAAN	The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Enrico S. Bertini, MD	Dr. Bertini has received personal compensation for serving as an employee of Bambino Gesu' Children's Resesarch Hospital.
Bryan Traynor, MD	The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Richard S. Finkel, MD, FAAN	Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Virginia A. Devonshire, MD	Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck- Serono. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Devonshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen . Dr. Devonshire has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for novartis. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for roche. Dr. Devonshire has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biogen .
Matthew J. Thurtell, MD	Dr. Thurtell has received publishing royalties from a publication relating to health care.
Douglas M. Sproule, MD	Dr. Sproule has received personal compensation for serving as an employee of Bridge Bio. Dr. Sproule has received personal compensation for serving as an employee of Novartis, Inc. Dr. Sproule has received stock or an ownership interest from Bridge Bio.
Krzysztof Bujarski, MD	Dr. Bujarski has nothing to disclose.
Amber Salter, PhD	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Sheryl Martin-Schild, MD, PhD, FAAN	No disclosure on file
Holger Kaube, MD	No disclosure on file
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Darryl C. De Vivo, MD, FAAN	Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Alberto L. Dubrovsky, MD	No disclosure on file
Marcelo C. Kremenchutzky, MD, FAAN	No disclosure on file
Helen Tremlett, PhD, BPharm	Dr. Tremlett has nothing to disclose.
Sarah Kremen, MD	Dr. Kremen has received publishing royalties from a publication relating to health care.
Thomas O. Crawford, MD	Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Walter R. Royal III, MD	No disclosure on file
Sung-Tsang Hsieh, MD, PhD, FAAN	No disclosure on file
James F. Paskavitz, MD	No disclosure on file
Tae-Kyeong Lee, MD	No disclosure on file
Paolo Barone, MD	No disclosure on file
Sun Ah Park, MD	No disclosure on file
Peter Novak, MD	Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care.
Mefkure Eraksoy, MD	Dr. Eraksoy has nothing to disclose.
Andres M. Villa, MD	Dr. Villa has nothing to disclose.
Sophie Drapier, MD	No disclosure on file
Marc Verin	Mr. Verin has nothing to disclose.
Paul Sauleau, MD	No disclosure on file
Kumar Rajamani, MD, FAAN	Dr. Rajamani has nothing to disclose.
Marilou I. Ching, MD	Dr. Ching has nothing to disclose.
Hahn Young Kim	No disclosure on file
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Siddharama Pawate, MD	The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Scott McGinnis, MD	Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Okan Dogu, MD	No disclosure on file
Antoine Gueguen, MD	An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
Laura N. Pirra	No disclosure on file
Wei Liu, MD	Dr. Liu has nothing to disclose.
Muhammad Farooq, MD	Dr. Farooq has nothing to disclose.
Rachel Goldmann Gross, MD	No disclosure on file
Gulden Akdal, MD	Dr. Akdal has nothing to disclose.
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
Olivier Beauchet, MD, PhD	No disclosure on file
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Michael Calloway	No disclosure on file
Chi-Chao Chao	Chi-Chao Chao has nothing to disclose.
Cordelia Erickson-Davis	No disclosure on file
Hye-Jin J. Kim	No disclosure on file
Masa-Aki Higuchi, MD	No disclosure on file
Ben M. Illigens, MD	Dr. Illigens has received personal compensation for serving as an employee of Target Health. Dr. Illigens has received personal compensation for serving as an employee of BC Platforms. Dr. Illigens has received personal compensation for serving as an employee of NOVA Discovery. Dr. Illigens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RDP Pharma. Dr. Illigens has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Biomind Labs. Dr. Illigens has a non-compensated relationship as a Director with Partners for Patients that is relevant to AAN interests or activities.
Jung-Ju Lee, MD, PhD	No disclosure on file
Ji-Yun Park	No disclosure on file
Jee Hoon Roh, MD, PhD	No disclosure on file
Tiphaine Rouaud	No disclosure on file
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Jennifer Schymick	No disclosure on file
Ole Suhr	The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam . The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akces. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. The institution of Ole Suhr has received research support from Swedish Heart and Lung Foundation.
Devraj Sukul	No disclosure on file
George Thomas	No disclosure on file
Umit H. Ulas, MD	No disclosure on file
David B. Watson, MD, FAAN	Dr. Watson has nothing to disclose.
Christopher Gomez, MD, PhD	Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Maiya Geddes, MD	No disclosure on file
Steven Z. Rapcsak, MD	Dr. Rapcsak has nothing to disclose.
Daniel Bandari, MD	The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Jennifer J. Manly, PhD	The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Gilberto Pizzolato, MD	No disclosure on file
Joseph S. Kass, MD, JD, FAAN	Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
William R. Tyor, MD, FAAN	The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Archit Bhatt, MD	No disclosure on file
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Katherine A. Riester, MPH	No disclosure on file
Richard F. Holub, MD	No disclosure on file
Alfred T. Frontera, MD, FAAN	No disclosure on file
Mehul P. Sampat, PhD	No disclosure on file
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Corey Goldsmith, MD, FAAN	Dr. Goldsmith has received publishing royalties from a publication relating to health care.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Aarti Sarwal, MD, FAAN	Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Anthony T. Yachnis, MD	No disclosure on file
Abdullahi Ibrahim, FAAN	No disclosure on file
Yakub W. Nyandaiti, MBBS	No disclosure on file
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Phyllis Faust	Phyllis Faust has nothing to disclose.
Mirla L. Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Adele D'Amico	No disclosure on file
Huana C. Marin, MD	No disclosure on file
Yong S. Lee, MD	No disclosure on file
Leslie C. Baxter, PhD	No disclosure on file
Gabriele Siciliano	Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Andrew Russman, DO, FAAN	Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
David Baker	No disclosure on file
Florencia Aguirre	No disclosure on file
Lauren B. Elman, MD	Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Ming-Jen Lee, MD, PhD	No disclosure on file
James Sheridan, PhD	No disclosure on file
Valdimir Vexler	No disclosure on file
Helene Brissart	No disclosure on file
Tomoya Kubota	No disclosure on file
Anna Czlonkowska, MD	Dr. Czlonkowska has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Bruno Stankoff, MD, PhD	The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Novraj Dhanjal, MD	No disclosure on file
Richard Wise	No disclosure on file
Joseph Giuffrida, PhD	No disclosure on file
Carlo Avolio, MD	No disclosure on file
Steven S. Schreiber, MD	Dr. Schreiber has nothing to disclose.
Vladimiro Sinay, MD	No disclosure on file
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Trina Johnson, MD	No disclosure on file
Ilaria Bartolomei	No disclosure on file
Martin A. Nogues	No disclosure on file
Jun Shimizu, MD, PhD	No disclosure on file
Reem F. Bunyan, MD	No disclosure on file
Belen Pascual, PhD	The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Maria C. Polidori, MD	No disclosure on file
Gereon Nelles, MD, PhD, FAAN	Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Antoine Moulignier, MD	No disclosure on file
Michal Szulc	No disclosure on file
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Regina Lam	No disclosure on file
Jennifer E. Vaughan, MD	No disclosure on file
Tomotaka Yamamoto	No disclosure on file
Terrence M. Li, MD, FAAN	No disclosure on file
Osama Sabri, MD, PhD	No disclosure on file
Aren Okello	No disclosure on file
Kristen A. Smith, MD	No disclosure on file
Michael Chilungu, MD	No disclosure on file
Babak Movassaghi, MD	No disclosure on file
Amie L. Hiller, MD	The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Kimiko Domoto-Reilly, MD	Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Nelson Hwynn, DO, FAAN	No disclosure on file
Brian R. Apatoff, MD, PhD	No disclosure on file
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Latt Latt Aung, MD	No disclosure on file
Haruhiko Banno, MD	No disclosure on file
Pratik D. Bhattacharya, MD, MPH	Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Patricio Brand, MD	Dr. Brand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Sol M. Cavanagh Campos, MD	Dr. Cavanagh Campos has nothing to disclose.
Karen Chen, PhD	No disclosure on file
Raymond T. Cheung, MD, FAAN	No disclosure on file
Hoe Chin Chua, MD	No disclosure on file
Teresa Coelho, MD	Dr. Coelho has nothing to disclose.
Mickael Cohen	No disclosure on file
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Emanuele D'Amico	Emanuele D'Amico has nothing to disclose.
Leonardo De Souza	No disclosure on file
Marc Dinkin, MD	Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
Sally Dunaway, DPT	Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Gisa Ellrichmann	No disclosure on file
Pamela Federighi	No disclosure on file
Wayne W. Feng, MD, FAAN	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Maria C. Fernandez, MD	Dr. Fernandez has nothing to disclose.
Suzanne Forrest	No disclosure on file
Pamela Foulds, MD	No disclosure on file
Ada Francia, MD	No disclosure on file
Cindy Fuller	No disclosure on file
Gabrielle Glick	No disclosure on file
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Anhar Hassan, MBBCH, FRACP, FRCPI, FAAN	The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Shizuo Hatashita, MD, PhD	No disclosure on file
Maya L. Henry, PhD	No disclosure on file
Ken Ikeda, MD, PhD	No disclosure on file
Simon Israeli-Korn, MD	No disclosure on file
Jill T. Jesurum, PhD	No disclosure on file
Cynthia Joyce	No disclosure on file
Klaus Kallenbach	No disclosure on file
Sucjoo Kim, MD	No disclosure on file
Irwin J. Kopin, MD	No disclosure on file
Vikas Kotagal, MD, FAAN	Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Michael J. Lyerly, MD, FAAN	Dr. Lyerly has nothing to disclose.
Luis F. Maia	No disclosure on file
Jessica Mandrioli	No disclosure on file
Warren Marks, MD	No disclosure on file
Logan McDaneld, MD, FAAN	No disclosure on file
Eric N. Miller, PhD	No disclosure on file
Scott Millis	Scott Millis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor & Francis. The institution of Scott Millis has received research support from NIH & NIDILRR.
Megan Montgomery	No disclosure on file
Brianna Morgan	No disclosure on file
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Kjell Morten Myhr, MD	No disclosure on file
Fernando L. Pagan, MD, FAAN	Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Ji-Young Park, MD	No disclosure on file
Allan Perel, MD, FAAN	Dr. Perel has received personal compensation for serving as an employee of Abbvie. The institution of Dr. Perel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Perel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Simona Pontecorvo	No disclosure on file
Massimiliano Prencipe, MD	No disclosure on file
Ann B. Ragin, PhD	No disclosure on file
Nishant S. Ranawat, MD	No disclosure on file
Anmar Razak, MD	Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Andrew Resnick, BS	No disclosure on file
Sandra R. Richman, MD	No disclosure on file
Laurence Salin	Laurence Salin has received personal compensation for serving as an employee of NeuroDerm.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Alessandro Serra, MD	Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Peyman Shirani, MD	No disclosure on file
Gen Sobue, MD	Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited..
Aimee Szewka, MD, FAAN	Dr. Szewka has nothing to disclose.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Vahid Tohidi, MD, PhD	Dr. Tohidi has nothing to disclose.
Mathieu Vokaer, MD	No disclosure on file
Kolawole W. Wahab, MD, FAAN	Dr. Wahab has nothing to disclose.
Konrad P. Weber, MD	Dr. Weber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weber has received intellectual property interests from a discovery or technology relating to health care. Dr. Weber has a non-compensated relationship as a Medical Advisor with MachineMD that is relevant to AAN interests or activities.
Mary Widmeyer, MD	No disclosure on file
Ahmed El-Dokla, MD, FAAN	Dr. El-Dokla has nothing to disclose.
Yessar M. Hussain, MD	The institution of Dr. Hussain has received research support from Alnylam Pharma.
Roberto Prado, MD, PhD	No disclosure on file
Giovanni L. Mancardi	No disclosure on file
P. Murali Doraiswamy	No disclosure on file
Constantine Farmakidis, MD, FAAN	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Nancy Hammond, MD, FAAN	Dr. Hammond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthline.
Zimbul Albo-Angelus, MD, PhD	No disclosure on file
Laura Allen, NP	Ms. Allen has nothing to disclose.
Cedric Annweiler, MD, PhD	No disclosure on file
Hossein Ansari, MD, FAAN	Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NOEMA Pharmaceutical . Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BIOHAVEN Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioDelivery Sciences International, Inc. . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Ansari has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck Pharmaceutical . Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceutical . Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MedLegal Network. Dr. Ansari has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Litogation Legal insight ( LITILI). Dr. Ansari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FOLAND, WICKENS, ROPER, HOFER & CRAWFORD, P.C.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Tamar Bacon	The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Jawad Bajwa, MD	No disclosure on file
Antoni Barrientos	No disclosure on file
Stefania Battistini, MD	No disclosure on file
Antonie G. Beiske Gjaever	No disclosure on file
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Ingrid K. Bjorna, MD	No disclosure on file
Svetlana Blitshteyn, MD, FAAN	Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Blitshteyn has received publishing royalties from a publication relating to health care. Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Healthcare Expert with Agency for Healthcare Quality and Research, US Health and Human Services.
H. Bockholt	No disclosure on file
Ashley Boller	No disclosure on file
Jonathan M. Brotchie, PhD	No disclosure on file
Alla Nikolajeuna Ser Bru	No disclosure on file
Maura Brunetti	No disclosure on file
Susan C. Byrne, MD	No disclosure on file
Dani Cabral, MD	No disclosure on file
Pasquale Calabrese, PhD	Dr. Calabrese has nothing to disclose.
Teresa Caloto, PhD	No disclosure on file
Daniel Capruso, PhD	No disclosure on file
Alan Carpenter, PhD	No disclosure on file
Clair M. Cascella, MD	No disclosure on file
Tagann Chaisam, MD	No disclosure on file
Athena L. Chen	No disclosure on file
Peii Chen	No disclosure on file
Yong Chen, MD	No disclosure on file
Philip Cherian, MD	No disclosure on file
James Cooper, PhD	Dr. Cooper has received personal compensation for serving as an employee of GSK. Dr. Cooper has stock in GSK.
Asa Cordle	No disclosure on file
David R. Curfman, MD	Dr. Curfman has nothing to disclose.
Kathleen Currey	No disclosure on file
Kathrin LaFaver, MD, FAAN	Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to AAN interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to AAN interests or activities.
Froeydis Dalene	No disclosure on file
Ayman A. Daoud, MD	No disclosure on file
Georgia M. Davies	No disclosure on file
Atbin Djamshidian	No disclosure on file
Elizabeth Dragan, MD	No disclosure on file
Travis Dunckley, PhD	No disclosure on file
Emily Dunn	No disclosure on file
Astrid Edland, MD	No disclosure on file
Adam B. Edwards, MD	Dr. Edwards has nothing to disclose.
Randi Eikeland, MD	No disclosure on file
Kaoutar El Hafsi	No disclosure on file
Andrew H. Evans, MB, BS	Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. The institution of Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluerock. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Encapsulate.
Alice Favaretto	No disclosure on file
Tea Fevr	No disclosure on file
Deborah Forst, MD	Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Amanda A. Forys, MSPH	No disclosure on file
Angeline Ngo, MD	Dr. Ngo has nothing to disclose.
Mohammad Fouladvand, MD	No disclosure on file
Aryn Gittis	No disclosure on file
Marlis Gonzalez-Fernandez, MD, PhD	No disclosure on file
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Waldo Guerrero, MD	Dr. Guerrero has nothing to disclose.
Maria del Pilar Guillermo Prieto Eibl, MD	Dr. Guillermo Prieto Eibl has nothing to disclose.
Suneel K. Gupta, PhD	No disclosure on file
Austin Hake, MD	No disclosure on file
Kerry Hamsher, PhD	No disclosure on file
Dietrich Haubenberger, MD, FAAN	Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Olaf Henriksen	No disclosure on file
Rachel L. Higbie, BA	No disclosure on file
Georg A. Hishaw, MD	No disclosure on file
Harald Olav Hovdal, MD	No disclosure on file
Hui Huang, MD, PhD	No disclosure on file
Hee Young Hwang	No disclosure on file
Diane L. Ito, MA	No disclosure on file
Jae Wond Jang, MD	No disclosure on file
Imad T. Jarjour, MD, FAAN	No disclosure on file
Laila K. Jarjour, MB ChB MPH	No disclosure on file
Nosheen J. Rafique	No disclosure on file
Gareth R. John	No disclosure on file
Tom H. Johnston, PhD	No disclosure on file
Roxanne L. Julius	No disclosure on file
Fumio Kanda, MD, PhD, FAAN	No disclosure on file
Kyung-Wook Kang, MD	No disclosure on file
Tulay Kansu, MD, FAAN	No disclosure on file
Sherron H. Kell, MD	No disclosure on file
Nasim R. Khadem	No disclosure on file
Rola Khedraki	No disclosure on file
Halfdan Kierulf, MD	No disclosure on file
Dong-eog Kim, MD	No disclosure on file
Hyon S. Kim, MD	No disclosure on file
Kwang-Ki Kim, MD	No disclosure on file
Sang-jin Kim, MD	No disclosure on file
Jacob Kitchener, MD	No disclosure on file
Grethe Kleveland, MD	No disclosure on file
Inna Kleyman, MD	Dr. Kleyman has nothing to disclose.
Terje Kristensen	No disclosure on file
Markus Krumbholz	Markus Krumbholz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme, Merck, Novartis, Roche. The institution of Markus Krumbholz has received research support from Merck.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Abhay Kumar, MD	Dr. Kumar has nothing to disclose.
Francois Lallement	No disclosure on file
Pierre Lecanuet	No disclosure on file
Kyung-Bok Lee, MD	No disclosure on file
Mechele Lee	No disclosure on file
Tina C. Lin, DO	No disclosure on file
Alan Lipschitz, MD	No disclosure on file
Alexandra J. Sequeira, MD	Dr. Sequeira has nothing to disclose.
Ranjani Manjunath, MSPH	No disclosure on file
Cecilia Marelli, MD	No disclosure on file
Jill M. Marjama-Lyons, MD	No disclosure on file
Shira Markowitz, MD	No disclosure on file
Pablo Martinez-Lage, MD	No disclosure on file
Kristina Martinu	No disclosure on file
Michele Mass, MD	No disclosure on file
Takashi Matsukawa, MD	No disclosure on file
Venkata Mattay, MD	No disclosure on file
Matthias Mehling, MD	The institution of Dr. Mehling has received research support from Swiss National Science Foundation. The institution of Dr. Mehling has received research support from Roche. The institution of Dr. Mehling has received research support from Merck.
Lilia Mesa, MD	No disclosure on file
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Rune Midgard, MD	No disclosure on file
James Moberly	No disclosure on file
Chiara Monaldini	No disclosure on file
Rachel L. Moreau	No disclosure on file
Johanna L. Morton, MD, MS	Dr. Morton has received personal compensation for serving as an employee of SOC Telemed. Dr. Morton has received personal compensation for serving as an employee of The Joint Commission.
Heather Moss, MD, PhD, FAAN	Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
Bruno C. Musch, MD	No disclosure on file
Lionel Naccache	No disclosure on file
Marcello Naccarato	No disclosure on file
Alexandra Nelson, MD, PhD	No disclosure on file
Ron Neumann, MD	No disclosure on file
Rita M. Nilsen	No disclosure on file
Paul Nisbet, PhD	No disclosure on file
Shiho Okuda, MD	No disclosure on file
Timna Onigman	No disclosure on file
Matthew J. Ostrander, MD	No disclosure on file
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Marios Pantzaris, MD	Dr. Pantzaris has nothing to disclose.
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Hasti Poya	No disclosure on file
Hana Prikrylova Vranova	No disclosure on file
Catherine H. Wuthrich, MD	No disclosure on file
Ashwini K. Rao	No disclosure on file
Paula D. Ravin, MD	No disclosure on file
Janakan Ravindran, MBBS	No disclosure on file
Sjur Reinertsen	No disclosure on file
Cornelia Reininger	No disclosure on file
Espartaco M. Ribeiro	No disclosure on file
Liliana Robles, MD	No disclosure on file
Liana Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to AAN interests or activities.
Francesca Rosini, MD	No disclosure on file
Sandra Ruby, MD	No disclosure on file
Suratno Sastro Sukarno, MD	No disclosure on file
Christoph J. Schankin, MD	The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grünenthal. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Schankin has stock in Zynnon.
Suroto Setijorumekso, MD, PhD, FAAN	No disclosure on file
Huma Sheikh, MD	Dr. Sheikh has nothing to disclose.
Kenneth J. Shulman, DO	No disclosure on file
Sara A. Simpson, MD	No disclosure on file
Iuliana Slesari	No disclosure on file
John N. Soltys, MD	Dr. Soltys has nothing to disclose.
Joshua A. Sonnen	No disclosure on file
Evangelia Sotiriou, MD	No disclosure on file
Bryan M. Spann, DO, PhD	No disclosure on file
Sheila G. Srinivasan, MBBS	No disclosure on file
Aleksandra C. Stark-Laudate, MD	Dr. Stark-Laudate has nothing to disclose.
David Staskin, MD	No disclosure on file
Timothy J. Steiner	No disclosure on file
Dietrich A. Stephan, PhD	Dr. Stephan has received personal compensation for serving as an employee of NeuBase Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from Peptilogics, Inc.. Dr. Stephan has received stock or an ownership interest from Sharp Edge Labs, Inc.. Dr. Stephan has received stock or an ownership interest from Pendulum Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from FarmaceuticalRx.
Shumaila Sultan, MD, FAAN	Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Arun Sundaram, MD, FRCP	No disclosure on file
Shin Takano, MD	No disclosure on file
Hiangkiat Tan	No disclosure on file
Mattea L. Tan	No disclosure on file
Sharief Taraman, MD	Dr. Taraman has received personal compensation for serving as an employee of Cognoa. Dr. Taraman has received personal compensation for serving as an employee of Pediatric Subspecialty Faculty. Dr. Taraman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics . Dr. Taraman has stock in Handzin. Dr. Taraman has stock in Cognoa. The institution of Dr. Taraman has received research support from Innovative Health Solutions. Dr. Taraman has received intellectual property interests from a discovery or technology relating to health care. Dr. Taraman has received intellectual property interests from a discovery or technology relating to health care. Dr. Taraman has received intellectual property interests from a discovery or technology relating to health care.
Sirinan Tazen, MD	No disclosure on file
Iyavut Thaipisuttikul, MD	No disclosure on file
Stuart R. Tomko, MD	No disclosure on file
Camilo Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Rebecca Traub, MD, FAAN	Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice.
Ching Piao Tsai, MD	No disclosure on file
Po-Heng Tsai, MD	No disclosure on file
Alan C. Tse, MD	No disclosure on file
Aaron Vinik	No disclosure on file
Sarah Wahlster, MD	Dr. Wahlster has nothing to disclose.
Len Walt, MD	No disclosure on file
Widjojo Sutedjo, MD	No disclosure on file
Thomas L. Winder, PhD, FACMG	Dr. Winder has nothing to disclose.
Jacqueline M. Winterkorn, MD PhD	No disclosure on file
Lars Wojtecki, MD, PhD	No disclosure on file
Lauren C. Flynn, DO	No disclosure on file
Francesco Marrosu, MD	No disclosure on file
Sarah Tomaszewski-Farias	No disclosure on file
Jose Matias	No disclosure on file
Umer Akbar, MD	Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Janice Wong, MD	Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Madaline B. Harrison, MD	Dr. Harrison has nothing to disclose.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Amrou Sarraj, MD	Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Wondwossen G. Tekle, MD	Dr. Tekle has nothing to disclose.
Leslie A. Benson, MD	The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Maureen A. Mealy, PhD, RN	No disclosure on file
Paula C. Azevedo, MD	Dr. Azevedo has nothing to disclose.
Carlos Otavio Brandao, MD, PhD	No disclosure on file
Anjail Sharrief, MD	The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Kushak Suchdev, MD	Dr. Suchdev has nothing to disclose.
Alireza Noorian, MD	No disclosure on file
Preet M. Varade, MD	Dr. Varade has nothing to disclose.
Barry M. Czeisler, MD, MS, MHPE, FAAN	Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroStat Consulting LLC. Dr. Czeisler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroStat Consulting LLC. Dr. Czeisler has stock in Brainspace. Dr. Czeisler has received publishing royalties from a publication relating to health care.
Qian Ma, MD, PhD	No disclosure on file
Frank A. Imarhiagbe, MD	No disclosure on file
Jared Cook	No disclosure on file
Jessica H. Goldstein, MD, FAAN	Dr. Goldstein has nothing to disclose.
Jingya Zhang, PhD	No disclosure on file
Richard D. Dortch, PhD	Dr. Dortch has nothing to disclose.
Sergio Lindembaum	No disclosure on file
Erika S. Horta, MD	Dr. Horta has nothing to disclose.
Karen Hirsch, MD	Dr. Hirsch has nothing to disclose.
Imad R. Khan, MD	The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke. The institution of Dr. Khan has received research support from National Heart Lung and Blood Institute. The institution of Dr. Khan has received research support from National Institute of Neurological Diseases and Stroke.
Syed I. Hussain, MD	Dr. Hussain has nothing to disclose.
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Umair Saeed, MD	No disclosure on file
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Joseph S. Chung, DO	No disclosure on file
Amir A. Sepehry	No disclosure on file
Catherine Tegeler	Ms. Tegeler has nothing to disclose.
Patrizia Casaccia, MD, PhD	No disclosure on file
Nyaz Didehbani, PhD	Dr. Didehbani has nothing to disclose.
Guy T. Helman	No disclosure on file
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
John M. Hourihane, MD	No disclosure on file
Husnu Efendi, MD	The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Amir Adeli, MD	Dr. Adeli has nothing to disclose.
Mary Jane Lim-Fat, MD, FRCPC	Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Lim Fat has received research support from Brain Cancer Canada.
Sanskriti Mishra, MD	No disclosure on file
Bardia Nourbakhsh, MD	Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics .
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Maria Cristina Arci Santos	No disclosure on file
Esha Khurana	No disclosure on file
Sarah J. Banks, PhD	No disclosure on file
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Adam M. Willis, MD	The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Francisco J. Varela, MD	Dr. Varela has nothing to disclose.
Anna E. Blanken	Ms. Blanken has nothing to disclose.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Elizabeth Diebolt	No disclosure on file
Margaret Esiri	Margaret Esiri has stock in Cytox Group.
Neha Safi, MD	No disclosure on file
Priyank Patel, MD	Dr. Patel has nothing to disclose.
Vijayaleskhmi Nair, MD	No disclosure on file
Shibani S. Mukerji, MD, PhD	Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
William Hayward, MD, PhD	No disclosure on file
Padraig E. O'Suilleabhain, MD, FAAN	The institution of Dr. O'Suilleabhain has received research support from ONO pharmaceutical. The institution of Dr. O'Suilleabhain has received research support from Integrated Research Laboratories.
Venkatachalam Mangeshkumar, MD, FAAN	No disclosure on file
John K. Lynch, DO, MPH	Dr. Lynch has nothing to disclose.
Ross Zafonte, DO	Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MYOMO. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kisbee. Dr. Zafonte has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. The institution of Dr. Zafonte has received research support from NIDILRR. The institution of Dr. Zafonte has received research support from NIH. The institution of Dr. Zafonte has received research support from FPHS study. Dr. Zafonte has received publishing royalties from a publication relating to health care.
Patrizia Ferrero	No disclosure on file
Nathan Tagg, MD	Dr. Tagg has stock in Apple, Birkshire Hathaway, Medtronic.
Klaus-Georg E. Werner, MD	No disclosure on file
Jennifer P. Rubin, MD	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Passage Bio.
Benjamin Emanuel, DO	Dr. Emanuel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback McAndrews Blessey.
Kwan Ng, MD, PhD	Dr. Ng has nothing to disclose.
Galyna Pushchinska, MD	No disclosure on file
Mark Anderson, MD	No disclosure on file
Christian M. Cabrera Kang, MD	No disclosure on file
Ryan Crooks, MD	Dr. Crooks has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Chubb.
Shyam S. Rao, MD	No disclosure on file
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Julia E. Staisch, MD	Dr. Staisch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Staisch has received research support from Michael J Fox.
Pooja Sofat, MBBS	Dr. Sofat has nothing to disclose.
Olanrewaju Agbe-Davies, MD, MBBS	No disclosure on file
Adam D. Wallace, MD	Dr. Wallace has nothing to disclose.
Devry M. Saenz, MD	No disclosure on file
Asaff Harel, MD	Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Rafael P. Dias-Carneiro, MD	No disclosure on file
Quang D. Vu, MD	No disclosure on file
Kanika Arora, MD	No disclosure on file
Alissa A. Chitlangia, MD	Dr. Chitlangia has nothing to disclose.
Quynh Pham, MD	No disclosure on file
Reuben Burshtein, MD	No disclosure on file
Mia Ko, DO	No disclosure on file
Danah Marafie, MD	Dr. Marafie has received research support from United States National Institute of Health.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from ��ɫ��.
Grant Iverson, PhD	Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sway Medical. Grant Iverson, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NanoDX. The institution of Grant Iverson, PhD has received research support from Wounded Warrior Project. Grant Iverson, PhD has received publishing royalties from a publication relating to health care. Grant Iverson, PhD has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with NeuroHealth, LLC.
Fariha Khalid, MD	No disclosure on file
Kelly Wong	No disclosure on file
Max R. Mandelbaum, MD, PhD	No disclosure on file
James Baier	No disclosure on file
GAMZE BALCI CAMSARI, MD	No disclosure on file
Hillary A. Williams, MD	No disclosure on file
Achint A. Patel	No disclosure on file
Brandon Seminatore, MD	No disclosure on file
Tuncay Gunduz, MD	The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Margarita M. Aulet-Leon	No disclosure on file
Keith R. Albrektson	No disclosure on file
Alejandra Gonzalez	No disclosure on file
Rik Ganguly	No disclosure on file
Thor D. Stein, MD, PhD	Dr. Stein has nothing to disclose.
Aysegul Gunduz	No disclosure on file
Cynthia C. Bamford, MD	No disclosure on file
Lauren C. Frey, MD	No disclosure on file
Jussara M. Khouri, MD	Dr. Khouri has nothing to disclose.
David C. McCarthy, Jr., MD	Dr. McCarthy has nothing to disclose.
Timothy Shepherd	No disclosure on file
Nicholas A. Frost, MD, PhD	The institution of Dr. Frost has received research support from Simons Foundation. The institution of Dr. Frost has received research support from National Institutes of Health.
Athanasios Evangeliou	No disclosure on file
William Panenka, MD	Dr. Panenka has nothing to disclose.
Sara K. Rostanski, MD	Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Alfredo H. Laffue, MD	Dr. Laffue has nothing to disclose.
Derek Clark, MD	No disclosure on file
Jaskiran Brar, MD	No disclosure on file
Alicia E. Bennett, DO	Dr. Bennett has nothing to disclose.
Ilana L. Kahn, MD	Dr. Kahn has nothing to disclose.
Jessica L. Winslow, MD	No disclosure on file
Tyler E. Gaston, MD	Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.
Andra L. Dingman, MD	Dr. Dingman has nothing to disclose.
David M. Auerbach, MD	No disclosure on file
Ravi Garg, MD	Dr. Garg has nothing to disclose.
Andre Y. Son	No disclosure on file
Harina K. Chahal, MD	No disclosure on file
Khaled Moussawi, MD, PhD	No disclosure on file
Mena Samaan, MD	No disclosure on file
Yiting Yang, MD	No disclosure on file
Murat Gonen	No disclosure on file
Sandra D. Cassard, ScD	No disclosure on file
Mohammed Elkider, MBBS	No disclosure on file
Lionel D. Vazquez-Figueroa, MD	Dr. Vazquez-Figueroa has nothing to disclose.
Daniel Korya, MD	No disclosure on file
Matthew N. Jaffa, DO	Dr. Jaffa has nothing to disclose.
Daniela M. Khouri, Jr., MD	Dr. Khouri has nothing to disclose.
Jose Antonio O. Pantangco	No disclosure on file
Kevin N. Ramdas, MD	No disclosure on file
Ersida Buraniqi, MD	No disclosure on file
Alexandra B. Kornbluh, MD	Dr. Kornbluh has nothing to disclose.
Sabrina Kuespert, PhD	No disclosure on file
Virendra R. Mishra, PhD	The institution of Prof. Mishra has received research support from Keep Memory Alive Young Scholar Award. The institution of Prof. Mishra has received research support from NINDS/NIA: R01NS117547-01. The institution of Prof. Mishra has received research support from NIGMS: P20GM109025.
Harald Pruss	Harald Pruss has nothing to disclose.
Harshil Shah, Jr., MBBS	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��